Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]
Wang X, Hua Y, Xu G et al. Int J Nanomedicine. 2019; 14:2637–2653. The authors advised that page 2641 contains the incorrect images of Figure 2B and Figure 2D due to an error in the program during the layout process.Read the original article.
Guardado en:
Autores principales: | Wang X, Hua Y, Xu G, Deng S, Yang D, Gao X |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/03a93313da2f4fe685f4c2111c095172 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex
por: Wang X, et al.
Publicado: (2019) -
Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1
por: Zhou P, et al.
Publicado: (2018) -
Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
por: Liu HM, et al.
Publicado: (2017) -
Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
por: Zatsepin TS, et al.
Publicado: (2016) -
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng Y, et al.
Publicado: (2018)